Former Executive Vice President, Chief Scientific Officer and Chief Medical Officer · ADMA BIOLOGICS, INC. (ADMA)

James Mond

A named executive officer of ADMA BIOLOGICS in every fiscal year CompBrief holds from FY2017 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,094,090

Salary $216,522Stock awards $129,250

FY2020: $1,195,348

3rd of 3 named executive officers at Adma Biologics by FY2021 total.

3 named officers on file for ADMA BIOLOGICS, FY2021

James Mond’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • ADMA’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ADMA BIOLOGICS’s whole pay program stands against its peers

  • ADMA BIOLOGICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ADMA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get James Mond’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

James Mond compensation by year

ADMA BIOLOGICS Summary Compensation Table · all 5 fiscal years held
In US dollars, as ADMA BIOLOGICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021
Salary$360,500$401,800$415,000$440,000$216,522
Bonus$127,712$117,325$207,500$233,200$0
Stock awards$0$0$0$116,600$129,250
Option awards$595,838$312,230$380,429$167,544$204,200
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other$86,161$214,094$234,493$238,004$544,118
Total$1,170,211$1,045,449$1,237,422$1,195,348$1,094,090

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ADMA BIOLOGICS, INC. DEF 14A filed April 28, 2022, accession 0001140361-22-016578, and prior-year filings.

How this page was built: the ADMA BIOLOGICS, INC. filed document, accession 0001140361-22-016578. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

$1.2M
$1.0M
$1.2M
$1.2M
$1.1M
FY17
FY18
FY19
FY20
FY21
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option5,625—$9.37
Option1,829—$5.96
Option459—$10.80
Option151,592—$3.66
Option12,188—$5.00
Option150,000—$3.71

Per the Outstanding Equity Awards at Fiscal Year-End table in ADMA BIOLOGICS, INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

ADMA BIOLOGICS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Adam GrossmanDirector President and Chief Executive Officer$4,361,250
Brian LenzExecutive Vice President and Chief Financial Officer$2,366,680
James Mond · this pageFormer Executive Vice President, Chief Scientific Officer and Chief Medical Officer$1,094,090

The full ADMA BIOLOGICS compensation record

free company brief

This page is one person within ADMA BIOLOGICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ADMA BIOLOGICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

James Mond's compensation dossier · One-time report. No refunds.